Pharma tariffs ‘not a huge risk’ for domestic companies, says Mizuho’s Jared Holz
CNBC’s “Fast Money” team discusses the potential impact of pharmaceutical tariffs with Jared Holz, healthcare equity strategist at Mizuho.
Independent thinking for complex markets and current events
CNBC’s “Fast Money” team discusses the potential impact of pharmaceutical tariffs with Jared Holz, healthcare equity strategist at Mizuho.